FDA NDC Directory · JSON-LD · Markdown

Fosrenol

NDC 54092-257 · HUMAN PRESCRIPTION DRUG · POWDER

Generic namelanthanum carbonate
Labeler / ManufacturerTakeda Pharmaceuticals America, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA204734
Dosage form / routePOWDER · ORAL
Active ingredientsLANTHANUM CARBONATE (1000 mg/1)
Marketing started20140924
Package count1

External sources

Source: openFDA. Public-domain (CC0).